Heat shock protein peptide vaccine appears safe, effective for glioblastoma patients

Chicago – A newly developed heat shock protein peptide vaccination appears to be safe and effective in treating patients with newly diagnosed glioblastoma (GBM), according to the results of a phase...

Source: Clinical Neurology News - June 16, 2016 Category: Neurology Source Type: news